
Accelerate Diagnostics AXDX
Quartalsbericht 2024-Q3
hinzugefügt 07.11.2024
Accelerate Diagnostics DSO 2011-2026 | AXDX
DSO Jährlich Accelerate Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 291 | 211 | 78 | 126 | 120 | 170 | 50.4 | 191 | 233 | 184 | 1.16 K | 194 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.16 K | 50.4 | 251 |
DSO Vierteljährlich Accelerate Diagnostics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.2 | 75 | - | 69.3 | 74.5 | 78.6 | - | 82.1 | 59.7 | 68.4 | 62.6 | 64 | 66.7 | 63.9 | 45.5 | 39.4 | 66.6 | 93 | 84.7 | 129 | 163 | 132 | 93.2 | 125 | 100 | 217 | 83.8 | 214 | 254 | 170 | 79.5 | 129 | 155 | 31.1 | 319 | 76.4 | 370 | 505 | 90.1 | 445 | 548 | 332 | 182 | 168 | 313 | 2.25 K | 8.37 K | 13.6 K | 3.07 K | 11.6 K | 306 | 306 | 69.8 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 13.6 K | 31.1 | 905 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 1.31 | -19.63 % | $ 1.74 M | ||
|
Agilent Technologies
A
|
63.8 | $ 112.11 | -1.0 % | $ 34.1 B | ||
|
Castle Biosciences
CSTL
|
50.2 | $ 19.11 | 1.19 % | $ 554 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.85 | -2.1 % | $ 479 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
61.3 | $ 142.72 | -0.36 % | $ 22.7 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 1.8 | - | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 19.85 | -3.12 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 93.78 | -2.99 % | $ 6.33 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 418.32 | -0.2 % | $ 12.1 B | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 038.75 | -0.3 % | $ 21.4 B | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 3.62 | - | $ 335 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
77.7 | $ 8.29 | -0.9 % | $ 1.06 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 152.19 | -4.36 % | $ 7.54 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.61 | -1.69 % | $ 417 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
81.5 | $ 188.15 | -4.45 % | $ 18.5 B | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
46.1 | $ 94.27 | -4.45 % | $ 11.8 B | ||
|
Personalis
PSNL
|
63.8 | $ 6.38 | -4.92 % | $ 569 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 116.56 | -0.45 % | $ 9.61 B | ||
|
Senseonics Holdings
SENS
|
1.04 | $ 5.72 | -1.72 % | $ 239 M | ||
|
Soleno Therapeutics
SLNO
|
27 | $ 53.0 | 0.01 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.25 | -6.67 % | $ 5.17 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 252.68 | -0.53 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 438.85 | -2.07 % | $ 165 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.56 | -3.63 % | $ 201 M | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 48.65 | -8.12 % | $ 2.91 B | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 8.21 | -2.61 % | $ 1.78 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 187.55 | -0.21 % | $ 20.8 B | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M |